Skip to content
Share

|

eAlerts

|

Register

|

Login
  • Services
    • News Services
    • Conference Coverage & Reporting
    • Expert Interviews & Discussion
    • Featured Content Creation
    • Multimedia
  • Specialties
  • Showcase
  • Clients
  • News & Insights
  • About
  • Contact

Day: March 25, 2024

FOXO1 fusion status aids paediatric local rhabdomyosarcoma risk assessment

A young boy looking sad as he received chemotherapy

Considering FOXO1 fusion status improves the risk assessment of children with localised rhabdomyosarcoma, suggest study findings published in Cancer.

Building relationships through trusted content for healthcare professionals

GET STARTED
A global leader in medical content

© 2023 Springer Healthcare Limited.
Part of the Springer Nature Group.

Twitter Icon-social_rss
Social Share
Contact
eAlerts
Register
Login
Terms of Use
Privacy Policy
Cookie Policy